AK Medical Holdings Limited (HKG: 1789)
Hong Kong
· Delayed Price · Currency is HKD
4.160
-0.120 (-2.80%)
Jan 15, 2025, 2:51 PM HKT
AK Medical Holdings Revenue
AK Medical Holdings had revenue of 657.10M CNY in the half year ending June 30, 2024, with 23.70% growth. This brings the company's revenue in the last twelve months to 1.10B, down -5.75% year-over-year. In the year 2023, AK Medical Holdings had annual revenue of 1.09B with 3.97% growth.
Revenue (ttm)
1.10B CNY
Revenue Growth
-5.75%
P/S Ratio
3.91
Revenue / Employee
1.05M CNY
Employees
1,052
Market Cap
4.66B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.09B | 41.82M | 3.97% |
Dec 31, 2022 | 1.05B | 290.61M | 38.17% |
Dec 31, 2021 | 761.44M | -273.95M | -26.46% |
Dec 31, 2020 | 1.04B | 108.68M | 11.73% |
Dec 31, 2019 | 926.71M | 326.14M | 54.31% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 26.04B |
Hansoh Pharmaceutical Group Company | 13.00B |
JD Health International | 58.84B |
WuXi Biologics | 18.39B |
Sinopharm Group | 634.32B |
Innovent Biologics | 8.01B |
Sino Biopharmaceutical | 29.86B |
Alibaba Health Information Technology | 31.39B |